The dialysis encephalopathy syndrome. Possible aluminum intoxication.
The aluminum content of muscle, bone and brain was measured in control subjects and in uremic patients on dialysis who had been maintained on phosphate-binding aluminum gels. The mean muscle aluminum was 14.8 ppm, and the trabecular-bone aluminum 98.5 ppm in the patients on dialysis, as compared with 1.2 and 2.4 in control subjects (P less than 0.05). Brain gray-matter aluminum values in a group of uremic patients on dialysis who died of a neurologic syndrome of unknown cause were 25 ppm as compared with 6.5 ppm in a group of uremic patients on dialysis who died of other causes and 2.2 ppm in control subjects. The fact that brain gray-matter aluminum was higher in all patients with the dialysis-associated encephalopathy syndrome than any of the control subjects or other uremic patients on dialysis suggests that this syndrome may be due to aluminum in intoxication.
D000535:Aluminum / Q000378:metabolism / Q000633:toxicity*; D000536:Aluminum Hydroxide / Q000009:adverse effects; D001842:Bone and Bones / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced*; D006801:Humans; D009132:Muscles / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects*; D013577:Syndrome; D013997:Time Factors; D014511:Uremia / Q000150:complications / Q000378:metabolism / Q000628:therapy
D000536:Aluminum Hydroxide; D000535:Aluminum